New hope for Crohn's: experimental drug SAR442970 enters phase 2 trial
NCT ID NCT06958536
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial is testing an experimental drug called SAR442970 in about 99 adults with moderate to severe Crohn's disease. Participants will receive either the drug or a placebo as a shot under the skin. The main goal is to see if the drug can improve the appearance of the gut lining during a scope exam after 16 weeks. The study lasts up to 168 weeks and includes a long-term extension where eligible participants can receive the drug openly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SAR442970 (an experimental drug given as a shot under the skin)
- What this could lead to
- If successful, this could point toward a new treatment option for people with moderate to severe Crohn's disease who haven't responded well to current therapies.
- What could go wrong
- This is an early phase 2 trial with only 99 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number 8400028
RECRUITINGMiami, Florida, 33134, United States
-
Investigational Site Number: 0360001
RECRUITINGFootscray, 3011, Australia
-
Investigational Site Number: 0360002
RECRUITINGBrisbane, Queensland, 4101, Australia
-
Investigational Site Number: 0360004
RECRUITINGKurralta Park, South Australia, 5037, Australia
-
Investigational Site Number: 0560001
RECRUITINGLeuven, B-3000, Belgium
-
Investigational Site Number: 1560001
RECRUITINGGuangzhou, 510655, China
-
Investigational Site Number: 1560006
RECRUITINGHangzhou, 310009, China
-
Investigational Site Number: 1560007
RECRUITINGShenyang, 110004, China
-
Investigational Site Number: 1560008
RECRUITINGChangsha, 410013, China
-
Investigational Site Number: 2030002
RECRUITINGBrno, JM, 61500, Czechia
-
Investigational Site Number: 2030003
RECRUITINGHradec Králové, 50012, Czechia
-
Investigational Site Number: 2030005
RECRUITINGSlaný, 274 01, Czechia
-
Investigational Site Number: 2500001
RECRUITINGMontpellier, 34090, France
-
Investigational Site Number: 2500002
RECRUITINGToulouse, 31059, France
-
Investigational Site Number: 2500003
RECRUITINGNice, 6000, France
-
Investigational Site Number: 2760001
RECRUITINGUlm, 89081, Germany
-
Investigational Site Number: 2760002
RECRUITINGMinden, Northwest, 32423, Germany
-
Investigational Site Number: 2760003
RECRUITINGJena, 07747, Germany
-
Investigational Site Number: 2760004
RECRUITINGKiel, 24105, Germany
-
Investigational Site Number: 3920001
RECRUITINGMorioka, 020-8505, Japan
-
Investigational Site Number: 3920002
RECRUITINGNishinomiya, 663-8501, Japan
-
Investigational Site Number: 3920003
RECRUITINGHamamatsu, 431-3192, Japan
-
Investigational Site Number: 3920004
RECRUITINGBunkyō City, 113-8519, Japan
-
Investigational Site Number: 3920005
RECRUITINGŌita, Oita Prefecture, 870-0033, Japan
-
Investigational Site Number: 3920006
RECRUITINGHamamatsu, Shizuoka, 432-8061, Japan
-
Investigational Site Number: 3920007
RECRUITINGKashiwa, Chiba, 277-0871, Japan
-
Investigational Site Number: 3920009
RECRUITINGHirosaki, 036-8545, Japan
-
Investigational Site Number: 6160001
RECRUITINGKrakow, 31-501, Poland
-
Investigational Site Number: 6160002
RECRUITINGWroclaw, Lower Silesian Voivodeship, 53-149, Poland
-
Investigational Site Number: 6160003
RECRUITINGWarsaw, 01-783, Poland
-
Investigational Site Number: 6160004
RECRUITINGWroclaw, 54-206, Poland
-
Investigational Site Number: 6160005
RECRUITINGLublin, 20-582, Poland
-
Investigational Site Number: 6160006
RECRUITINGSopot, 81-756, Poland
-
Investigational Site Number: 6160008
RECRUITINGWarsaw, 00-189, Poland
-
Investigational Site Number: 7100003
RECRUITINGJohannesburg, 1619, South Africa
-
Investigational Site Number: 7240001
RECRUITINGMadrid, 28046, Spain
-
Investigational Site Number: 7240002
RECRUITINGMadrid, 28003, Spain
-
Investigational Site Number: 7240003
RECRUITINGSeville, 41009, Spain
-
Investigational Site Number: 8260001
RECRUITINGLondon, SE1 7EH, United Kingdom
-
Investigational Site Number: 8260002
RECRUITINGLondon, HA8 0AD, United Kingdom
-
Investigational Site Number: 8260004
RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Investigational Site Number: 8260005
RECRUITINGLondon, E11 1NR, United Kingdom
-
Investigational Site Number: 8260007
RECRUITINGBury, BL9 7TD, United Kingdom
-
Investigational Site Number: 8400001
RECRUITINGLancaster, California, 93534, United States
-
Investigational Site Number: 8400002
RECRUITINGFredericksburg, Texas, 78229, United States
-
Investigational Site Number: 8400003
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
Investigational Site Number: 8400005
RECRUITINGEscondido, California, 92025, United States
-
Investigational Site Number: 8400006
RECRUITINGKansas City, Kansas, 66160, United States
-
Investigational Site Number: 8400007
RECRUITINGOrlando, Florida, 32804, United States
-
Investigational Site Number: 8400008
RECRUITINGWyoming, Michigan, 49519, United States
-
Investigational Site Number: 8400009
RECRUITINGHarrisburg, Pennsylvania, 17110, United States
-
Investigational Site Number: 8400011
RECRUITINGPalmetto Bay, Florida, 33176, United States
-
Investigational Site Number: 8400012
RECRUITINGMiami, Florida, 33136, United States
-
Investigational Site Number: 8400013
RECRUITINGSt Louis, Missouri, 63110, United States
-
Investigational Site Number: 8400015
RECRUITINGLighthouse PT, Florida, 33064, United States
-
Investigational Site Number: 8400016
RECRUITINGOgden, Utah, 84405, United States
-
Investigational Site Number: 8400017
RECRUITINGKissimmee, Florida, 34741, United States
-
Investigational Site Number: 8400019
RECRUITINGMarietta, Georgia, 30060, United States
-
Investigational Site Number: 8400022
RECRUITINGBoston, Massachusetts, 02115, United States
-
Investigational Site Number: 8400024
RECRUITINGTucson, Arizona, 85724, United States
-
Investigational Site Number: 8400025
RECRUITINGIowa City, Iowa, 52242, United States
-
Investigational Site Number: 8400027
RECRUITINGRichmond, Virginia, 23249, United States
-
Investigative Site: 1560002
RECRUITINGShanghai, 200092, China
-
Investigative Site: 1560003
RECRUITINGChangsha, 410011, China
-
Investigative Site: 1560004
RECRUITINGNanchang, 330006, China
-
Investigative Site: 1560005
RECRUITINGChangzhou, 213003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two-Drug cocktail aims to tame stubborn Crohn's disease
- Could Two-Drug cocktails tame stubborn inflammatory bowel disease?
- Could stopping acid reflux drugs improve IBD treatment?
- Placenta cells could tame Crohn's inflammation
- New daily pill aims to tame Crohn's Flare-Ups
- New oral pill H021 aims to tame Crohn's Flare-Ups